BENF.NASDAQBeneficient

8-K: Beneficient Faces Nasdaq Delisting Over Bid Price and Delayed Annual Report

Sentiment:

Delisting Notice


Beneficient received a delisting notice from Nasdaq due to its Class A common stock trading below the $1.00 minimum bid price and its failure to timely file its Annual Report on Form 10-K.

Delay expectedThe company has not yet filed its Annual Report on Form 10-K for the fiscal year ending March 31, 2025, which is a violation of Nasdaq's periodic reporting requirement.
Worse than expectedReceived a delisting notice from Nasdaq.Failed to meet the minimum $1.00 bid price requirement for its Class A common stock.Failed to timely file its Annual Report on Form 10-K for the fiscal year ending March 31, 2025.

Summary

  • Beneficient received a delisting notice from The Nasdaq Stock Market LLC on July 16, 2025.
  • The notice cited continued non-compliance with Nasdaq Listing Rule 5550(a)(2) (Bid Price Requirement), as the Class A common stock closed below the $1.00 per share minimum threshold for 30 consecutive business days, failing to regain compliance by July 14, 2025.
  • Additionally, the company has not yet filed its Annual Report on Form 10-K for the fiscal year ending March 31, 2025, which constitutes non-compliance with Nasdaq Listing Rule 5250(c)(1) (Periodic Reporting Requirement) and serves as a separate basis for delisting.
  • The company plans to timely request a hearing before the Nasdaq Hearings Panel to appeal the delisting determination and seek an extension of the automatic stay to ensure continued trading.
  • A press release announcing the receipt of the Determination Letter was issued on July 18, 2025.

Sentiment

Score: 2

Explanation: The company faces significant challenges including a delisting notice from Nasdaq due to both a low bid price and a failure to file its annual report. While it plans to appeal, there is no assurance of success, indicating a highly negative outlook.

Negatives

  • Received a delisting notice from Nasdaq due to multiple non-compliance issues.
  • Failed to maintain the minimum $1.00 bid price for its Class A common stock for 30 consecutive business days, failing to regain compliance by July 14, 2025.
  • Failed to timely file its Annual Report on Form 10-K for the fiscal year ending March 31, 2025.
  • Securities are subject to delisting from Nasdaq.
  • No assurance that the Nasdaq Hearings Panel will grant the request for continued listing or an extension.
  • The delisting process will incur substantial costs and divert management's attention and resources.

Risks

  • The Nasdaq Hearings Panel may not grant the company's request for continued listing.
  • Even if an extension is granted, the company may not be able to timely satisfy the terms of the Panel's decision to remain listed on Nasdaq.
  • Substantial costs and diversion of management's attention and resources due to the delisting matters.
  • Future events or results could be materially different from forward-looking statements due to various factors, including the outcome of the hearing and the ability to cure deficiencies.

Future Outlook

The company plans to request a hearing before the Nasdaq Hearings Panel and submit a request for a further extension of the automatic stay to ensure continued trading. It will present a plan to evidence compliance with all applicable listing criteria. However, there is no assurance that the Panel will grant the request for continued listing or an extension, or that the company will be able to satisfy the terms of any granted extension.

Management Comments

  • The Company plans to timely request a hearing and a stay of any suspension action by Nasdaq at least pending the ultimate outcome of the hearing process and the expiration of any extension period that may be granted to the Company following the hearing.
  • At the hearing, the Company will present its plan to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market and request an extension of time to do so.
  • While the Company is taking definitive steps to evidence compliance with the applicable listing criteria as soon as practicable, there can be no assurance that the Panel will grant the Company’s request for continued listing on Nasdaq.

Industry Context

Beneficient operates as a technology-enabled platform, AltAccess, providing exit opportunities and primary capital solutions, along with trust and custody services, to holders of alternative assets. It targets mid-to-high net worth individuals, small-to-midsized institutions, and General Partners. Its subsidiary, Beneficient Fiduciary Financial, L.L.C., is chartered under the State of Kansas Technology-Enabled Fiduciary Financial Institution (TEFFI) Act and is subject to regulatory oversight. The current delisting notice highlights the challenges smaller or emerging companies in specialized financial technology sectors can face in meeting public market listing requirements, particularly concerning share price stability and timely financial reporting.

Comparison to Industry Standards

  • No specific financial or operational metrics are provided within the document to enable direct comparison to industry benchmarks or comparable companies. The issues detailed pertain to general Nasdaq listing compliance, specifically the minimum bid price requirement and timely financial reporting, rather than industry-specific performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Non-compliance with Listing RulesFailure to meet Nasdaq Listing Rule 5550(a)(2) (Bid Price Requirement) and Nasdaq Listing Rule 5250(c)(1) (Periodic Reporting Requirement).2025-07-16Significant negative impact on corporate governance and investor confidence, leading to potential delisting and increased regulatory scrutiny.

Legal Proceedings

  • Nasdaq initiated delisting proceedings due to non-compliance with listing rules, specifically the minimum bid price requirement and the periodic reporting requirement.

Stakeholder Impact

  • Shareholders face significant risk of delisting, which could severely impact liquidity and the value of their investment.
  • Employees may experience uncertainty regarding the company's future and its ability to operate as a publicly traded entity.
  • Customers and partners may perceive increased operational risk due to the company's non-compliance with listing standards.

Next Steps

  • Timely request a hearing before the Nasdaq Hearings Panel.
  • Timely submit a request for a further extension of the automatic stay to ensure continued trading.
  • Present a plan to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market at the hearing.
  • Seek an extension of time to regain compliance.

Key Dates

DateDescription
2025-01-17Received initial letter from Nasdaq regarding non-compliance with the Bid Price Requirement.
2025-03-31Fiscal year end for which the Annual Report on Form 10-K was not timely filed.
2025-07-14Deadline to regain compliance with the Bid Price Requirement; company remained non-compliant.
2025-07-16Received Determination Letter from Nasdaq regarding continued non-compliance and potential delisting.
2025-07-18Issued a press release announcing receipt of the Determination Letter.

Recommendation

strong sell

Keywords

Beneficient, BENF, Nasdaq, Delisting, Bid Price Requirement, Form 10-K, Periodic Reporting, Nasdaq Listing Rules, Corporate Governance, Financial Reporting, Alternative Assets, AltAccess

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.